Background: To compare accuracy in intraocular lens (IOL) power calculation in eyes undergoing combined cataract and Descemet stripping and automated endothelial keratoplasty (C-DSAEK) surgery of the following formulas: Barrett Universal II, EVO, Haigis, Hoffer Q, Holladay 2, Kane and SRK/T.
Methods: 72 eyes from 72 patients (38 males, (53%)) with a mean age 68.08 ± 8.
Purpose: We investigated the natural history of retinal dystrophy owing to variants in the MYO7A gene.
Methods: Fifty-three patients (mean age, 33.6 ± 16.
Biallelic mutations in the RPE65 gene affect nearly 8% of Leber Congenital Amaurosis and 2% of Retinitis Pigmentosa cases. Voretigene neparvovec (VN) is the first gene therapy approach approved for their treatment. To date, real life experience has demonstrated functional improvements following VN treatment, which are consistent with the clinical trials outcomes.
View Article and Find Full Text PDFPurpose: To assess the efficacy of voretigene neparvovec (VN) treatment by objective fixation stability and chromatic pupillometry testing in clinical practice.
Design: Retrospective cohort study with longitudinal follow-up.
Subjects: Twelve patients (aged 7-34 years) with RPE65-related inherited retinal dystrophies were treated at the same center with VN in both eyes.
Background: Telemedicine, a term that encompasses several applications and tasks, generally involves the remote management and treatment of patients by physicians. It is known as transversal telemedicine when practiced among health care professionals (HCPs).
Objective: We describe the experience of implementing our telemedicine Eumeda platform for HCPs over the last 10 years.